Temazepam: Mechanism of Action and Side Effects
How Temazepam Works
Temazepam is a benzodiazepine that enhances GABA (gamma-aminobutyric acid) neurotransmission in the central nervous system, producing sedative-hypnotic effects that improve sleep onset and maintenance. 1
Pharmacological Mechanism
- Temazepam binds to benzodiazepine receptors at the GABA-A receptor complex, potentiating the inhibitory effects of GABA and resulting in CNS depression that facilitates sleep 2, 3
- The drug acts as a minor metabolite of diazepam with specific hypnotic properties 3
Pharmacokinetic Profile
- Peak plasma concentrations occur approximately 3 hours after oral administration, which explains why temazepam is more effective for sleep maintenance than sleep onset 2, 4
- Mean elimination half-life is 10-15 hours (range 5-11 hours, longer in elderly patients), classifying it as an intermediate-acting benzodiazepine 2, 3, 4
- No clinically significant active metabolites are produced, reducing the risk of prolonged sedation compared to longer-acting benzodiazepines like flurazepam 3, 4
Clinical Effects on Sleep Architecture
- Temazepam 15 mg reduces subjective sleep latency by approximately 20 minutes and increases total sleep time significantly 5
- Temazepam 30 mg reduces sleep latency by 40-45 minutes and increases total sleep time by 53-55 minutes compared to placebo 5, 6
- Wake after sleep onset (WASO) is significantly reduced, making it effective for middle-of-night awakenings 5, 7
- Sleep efficiency improves with both subjective and objective measurements 5
Side Effects of Temazepam
Common Side Effects (Most Frequent)
The FDA-approved labeling identifies these as the most common adverse effects: 1
- Drowsiness - most frequently reported
- Headache
- Tiredness/fatigue
- Nervousness
- Dizziness
- Nausea
- Next-day residual drowsiness - patients may not feel fully awake the morning after use 1
Serious Side Effects Requiring Immediate Medical Attention
Complex Sleep Behaviors (FDA Black Box Warning): 1
- Sleep-driving, sleep-eating, sleep-walking, and engaging in activities while not fully awake with no memory of the events
- Risk increases when combined with alcohol or other CNS depressants 1
Respiratory Depression and CNS Depression: 1
- Severe drowsiness, slowed or stopped breathing, coma, and death can occur, especially when combined with opioids, alcohol, or other CNS depressants 1
- This represents a critical drug interaction requiring emergency intervention 1
Psychiatric and Behavioral Effects: 1
- Abnormal thoughts and behavior including increased aggression, confusion, agitation, hallucinations 1
- Worsening of depression and suicidal thoughts or actions 1
- Delirium, paranoia, and loss of touch with reality in cases of abuse or misuse 1
Severe Allergic Reactions: 1
- Swelling of tongue or throat, difficulty breathing, nausea and vomiting requiring emergency treatment 1
Abuse, Dependence, and Withdrawal Risks
Temazepam is a Schedule IV controlled substance with significant potential for abuse, misuse, and addiction: 1
- Physical dependence develops even with prescribed use, and abrupt discontinuation causes serious withdrawal symptoms 1
- Withdrawal symptoms include seizures, severe mental status changes, hallucinations, extreme agitation, suicidal thoughts, and potentially life-threatening reactions 1
- Some withdrawal symptoms can persist for weeks to over 12 months, including anxiety, memory problems, depression, insomnia, paresthesias, weakness, tremor, and tinnitus 1
- Gradual tapering is mandatory - never stop temazepam suddenly 1
Cognitive and Psychomotor Impairment
- Daytime sedation and impaired psychomotor function can occur, particularly at doses of 30 mg or higher 3
- Memory impairment has been documented in systematic assessments 5
- Patients must not drive or operate heavy machinery until they know how temazepam affects them 1
Age-Related Considerations
In elderly patients (≥70 years): 5
- Longer elimination half-life increases risk of accumulation 3
- Dose reduction to 7.5-15 mg is recommended for geriatric or debilitated patients 1, 4
- Lower incidence of adverse effects at 7.5 mg dose with maintained efficacy in elderly insomniacs 8
Incidence and Severity Profile
The overall incidence of adverse effects is relatively low: 9
- Only 7.8% of patients reported adverse effects in controlled trials of older adults over 8 weeks 9
- Adverse effects are typically mild in severity and decrease over the treatment course 9
- Behavioral tolerance to adverse effects develops over time 9
Special Warnings and Contraindications
Temazepam is contraindicated in: 1
- Patients with known hypersensitivity to temazepam or benzodiazepines 1
Use with extreme caution in: 1
- Pregnancy - may cause birth defects or harm to the unborn baby 1
- Breastfeeding - passes into breast milk and may harm the infant 1
- History of depression, mental illness, or suicidal ideation 1
- History of substance abuse or addiction 1, 7
- Lung disease or breathing problems - risk of respiratory depression 1
Duration of Safe Use
Temazepam is approved only for short-term use: 1
- Safety and efficacy established for 7-10 days of treatment 1
- Safety beyond 2 weeks is not established 1
- The American Academy of Sleep Medicine recommends concurrent cognitive behavioral therapy for insomnia (CBT-I) to provide sustainable benefits beyond medication discontinuation 7
Critical Drug Interactions
Never combine temazepam with: 1
- Opioid medications - causes severe respiratory depression, coma, and death 1
- Alcohol - dramatically increases sedation and risk of complex sleep behaviors 1
- Other CNS depressants unless specifically directed by a healthcare provider 1
Common Pitfalls to Avoid
- Taking temazepam without allowing 7-8 hours for sleep increases risk of next-day impairment 1
- Using temazepam as monotherapy without CBT-I results in loss of therapeutic gains upon discontinuation 7
- Abrupt discontinuation rather than gradual tapering causes severe withdrawal 1
- Combining with alcohol or other sedatives exponentially increases risk of serious adverse events 1